Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
American Journal of Ophthalmology|March 14, 2019
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! ProjectAlessandro Invernizzi, Vuong Nguyen, Kelvin Teo, et al.Ophthalmology. Retina|February 13, 2022
North Carolina Macular Dystrophy: Long-term Follow-up of the Original FamilyKent W Small, Robert Wiggins, Nitin Udar, et al.Molecular Vision|June 1, 2006
Further support of the role of CYP1B1 in patients with Peters anomalyAndrea Vincent, Gail Billingsley, Megan Priston, et al.The Clinical Neuropsychologist|February 2, 2013
Efficacy of the ANAM General Neuropsychological Screening Battery (ANAM GNS) for detecting neurocognitive impairment in a mixed clinical sampleJonathan Woodhouse, Daniel J Heyanka, Jim Scott, et al.Frontiers in Molecular Biosciences|September 2, 2022
Less is more: Enterobactin concentration dependency in copper tolerance and toxicityDaiana Romina Peralta, Juan Vicente Farizano, Natalia Bulacio Gil, et al.Ophthalmic Genetics|December 13, 2021
Best Vitelliform Macular Dystrophy (BVMD) is a phenocopy of North Carolina Macular Dystrophy (NCMD/MCDR1)Kent W Small, Lee M Jampol, Benjamin Bakall, et al.Frontiers in Microbiology|February 16, 2026
Interspecies interactions among sugarcane-associated bacteria and their impact on plant growth promotion traitsCésar Justiniano Fascio, Anna Carolina Rubio Molina, Benyi Juliana Marin-Gallego, et al.Plos One|May 5, 2017
Beneficial rhizobacteria immobilized in nanofibers for potential application as soybean seed bioinoculantsPriscilla Romina De Gregorio, Gabriela Michavila, Lenise Ricciardi Muller, et al.Retina (Philadelphia, Pa.)|March 9, 2023
OUTCOMES OF SWITCHING FROM PROACTIVE TO REACTIVE TREATMENT AFTER DEVELOPING ADVANCED CENTRAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONElisa E Cornish, Vuong Nguyen, Martin Puzo, et al.Molecular Vision|September 16, 2021
A novel duplication involving <i>PRDM13</i> in a Turkish family supports its role in North Carolina macular dystrophy (NCMD/MCDR1)Kent W Small, Stijn Van de Sompele, Karen Nuytemans, et al.Pageof 3